NCT00497328View on ClinicalTrials.gov

COmbined N-acetylcysteine and Bicarbonate in PCI To Reduce Adverse Side Effect of contrasT

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

477

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Contrast Induced Nephropathy
Interventions
DRUG

N-acetylcysteine

DRUG

Sodium Bicarbonate

Trial Locations (1)

119074

The Heart Institute, Singapore

All Listed Sponsors
lead

National University Hospital, Singapore

OTHER

NCT00497328 - COmbined N-acetylcysteine and Bicarbonate in PCI To Reduce Adverse Side Effect of contrasT | Biotech Hunter | Biotech Hunter